GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Motus GI Holdings MOTS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2023

Revenue

$319,000

FY2015FY2023

Net income

−$12.9m

FY2015FY2023

Free cash flow

−$11.5m

FY2015FY2023

Shareholders' equity

$2.7m

FY2015FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$319,000$592,000$391,000$98,000$107,000$36,000$7,000——
Research and development$3.5m$5.6m$5.3m$5.6m$9.0m$6.0m$4.3m$3.1m$3.2m
Operating income−$11.9m−$17.9m−$17.9m−$19.0m−$23.4m−$18.9m−$13.0m−$6.0m−$5.3m
Net income−$12.9m−$18.1m−$18.9m−$19.6m−$22.6m−$22.3m−$13.2m−$8.0m−$6.0m
Diluted earnings per share-20.54-58.40-117.46-155.55-235.35-412.17-378.22-132.83-9.57

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$7.2m$17.6m$26.1m$24.1m$32.3m$23.0m$9.2m$12.2m$1.7m
Cash and short-term investments$5.0m$14.0m$22.6m$20.8m$28.7m$21.1m$7.0m$11.6m$1.3m
Total liabilities$4.5m$14.7m$16.4m$12.8m$13.9m$4.4m$3.6m$2.2m$5.4m
Debt$2.5m$11.4m$12.1m$8.8m$8.8m—$250,000—$4.7m
Shareholders' equity$2.7m$3.0m$9.7m$11.3m$18.3m$18.5m$5.5m$10.0m−$3.7m
Shares outstanding1m0m0m0m0m0m0m0m1m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$11.4m−$17.5m−$14.4m−$17.0m−$19.9m−$14.9m−$10.4m−$6.1m−$4.9m
Capital spending−$104,000−$224,000−$470,000−$88,000−$468,000−$547,000−$707,000−$30,000−$68,000
Free cash flow−$11.5m−$17.7m−$14.9m−$17.1m−$20.4m−$15.5m−$11.1m−$6.2m−$5.0m
Dividends paid−$1.5m————————

Latest quarters

By quarter end

Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022
Revenue$64,000$64,000$86,000$113,000$56,000$109,000$278,000$185,000
Operating income−$2.0m−$2.5m−$2.4m−$2.7m−$4.4m−$4.0m−$4.7m−$4.6m
Net income−$2.1m−$2.8m−$2.7m−$3.0m−$4.4m−$3.9m−$5.2m−$5.7m
Diluted earnings per share-3.37-4.48-4.28-4.79-7.05-12.65-16.86-18.36
Cash from operations−$2.0m−$2.0m−$1.0m−$2.0m−$4.0m−$4.0m−$3.0m−$4.0m
Total assets$7.1m$7.2m$8.5m$11.7m$12.2m$17.6m$17.4m$20.1m
Cash and short-term investments—$5.0m$5.7m$8.5m$8.6m$14.0m$13.3m$15.8m
Debt$669,000$2.4m$9.4m$10.1m$10.7m$11.3m$11.8m$11.8m
Shareholders' equity$3.1m$2.7m−$2.5m−$963,000−$1.1m$3.0m$762,000$4.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue48.2%54.7%—
Operating income-14.5%-8.9%—
Net income-13.1%-10.4%—

Share price return

Finished calendar years

20252024202320222021202020192018
Return76700%-99%-87%-89%-48%-59%-14%-37%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 2 Nov 2023
  • 20-to-1 reverse split · 26 Jul 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.